AzTrials
AzTrials

HealthyNCT07700511

Healthy Volunteer Recruitment and Characterization for NINDS Studies

An observational study of Healthy, run by National Institute of Neurological Disorders and Stroke (NINDS) at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Background: The National Institute of Neurological Disorders and Stroke (NINDS) often enrolls healthy volunteers in certain studies. These studies allow researchers to look for causes of diseases and disorders by comparing affected people to healthy ones. Read more about this study

Who is it for?
Ages 18 to 110 yearsHealthy volunteers can take part
Conditions the study is for
Healthy
How many people
500 participants
Where
1 siteUnited States
Study dates
8 Feb 2027to 8 Jan 2035
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 110 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy Volunteers

Who may be able to join

  • To be eligible to participate in this study, an individual must meet all the following criteria:
  • Stated interest in, and availability for, participating in NINDS studies and willingness to comply with the procedures of this protocol.
  • At least 18 years of age.
  • Ability to understand and willingness to sign a written informed consent document.
  • Fluent in English, or another language that allows the use of a validated MoCA or MoCA Duo to be completed (see the following list of languages Paper (mocacognition.com) or Digital tools (mocacognition.com))

Who cannot join

  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • Major neurological or neurobehavioral disorder, such as seizure disorder, multiple sclerosis, major depression, or schizophrenia.
  • Substance use disorder or illicit substance use.
  • Deafness or blindness to a degree which would make participation in studies impossible, e.g., inability to communicate with investigators or read instructions.
  • Identified major health concerns (e.g., uncontrolled diabetes mellitus, congestive heart failure, liver cirrhosis, malignancy requiring ongoing cytotoxic chemotherapy, immunotherapy, or radiation) as evidenced by screening medical history.
  • Presence of implanted electronic devices, e.g., pacemakers, or other implanted object(s) making MRI unsafe or whose safety cannot be ascertained.
  • Inability to tolerate MRI scanning for any reason.
  • Pregnancy.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Eric M Wassermann, M.D. contact

(301) 496-0151

wassermanne@nih.gov

United States1 site
  • National Institutes of Health Clinical Center

    Bethesda, Maryland, 20892

    Eric Wassermann, M.D., 301-496-0151, wassermanne@nih.gov

    NIH Clinical Center Office of Patient Recruitment (OPR), (800) 411-1222 ext. TTY dial 711, ccopr@nih.gov

Other trials in United States

About this study

Background:

The National Institute of Neurological Disorders and Stroke (NINDS) often enrolls healthy volunteers in certain studies. These studies allow researchers to look for causes of diseases and disorders by comparing affected people to healthy ones. Prescreening lets volunteers participate in multiple studies without having to repeat the screening tests each time. Having a registry of prescreened volunteers also makes it easier for researchers to reach people willing to participate in their studies.

Read more

Objective:

To create a registry of healthy volunteers who have been prescreened for NINDS research studies.

Eligibility:

Healthy people aged 18 years and older.

Design:

Participants will have 1 clinic visit for prescreening. This visit will take about 5 hours. The visit may be spread across 1 to 3 days.

Participants will have the following procedures:

A physical exam, including height, weight, and vital signs.

A review of their medical history and medications. They will also provide personal data such as age, sex, and years of education.

An exam of their nervous system. This will include tests of their strength and reflexes, following an object with their eyes, and other tasks.

Cognitive tests. These tests will check their memory, attention, and thinking.

A magnetic resonance imaging (MRI) scan. They will lie on a table that slides into a cylinder; Magnetic fields will create images of their brain.

Handedness. They will complete a questionnaire about what hand they use for most tasks.

Participants may remain on the healthy volunteers list for 2 years. If they wish to participate longer, they will need to return to repeat all of the screening tests.

Read the detailed description

Study Description:

This protocol will create a registry of healthy volunteers for intramural NINDS. It will provide a vehicle for recruiting, examination, and preliminary testing of healthy research volunteers for NINDS studies. We plan to retain data for use in future research by creating a repository.

Objectives:

To provide a centralized and standardized service for recruiting, screening, and characterizing healthy volunteers by creating a repository for secondary research

Conditions
Healthy
Keywords
Healthy Volunteer, Healthy Participant, Pre-screening

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07700511
Study groupRoleWhat they receive
Healthy volunteersHealthy volunteers

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. To screen and create a temporary list of volunteers in good health for participation in NINDS studies (Volunteer List) in order to reduce costs, inconvenience to volunteers, and duplication of effort.

    Measured: From enrollment/consent until withdrawal from the registry or study closure.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2026
  2. Study start8 Feb 2027 (estimated)
  3. Primary completion8 Jan 2035 (estimated)
  4. Study completion8 Jan 2035 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07700511
Sponsor's protocol ID
10002262
Other IDs
002262-N
Status last verified
8 Jul 2026
First submitted
11 Jul 2026
Last updated
14 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy, run by National Institute of Neurological Disorders and Stroke (NINDS) at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 14 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eric M Wassermann, M.D. ((301) 496-0151, wassermanne@nih.gov), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To screen and create a temporary list of volunteers in good health for participation in NINDS studies (Volunteer List) in order to reduce costs, inconvenience to volunteers, and duplication of effort. (time frame: From enrollment/consent until withdrawal from the registry or study closure.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in